Target intelligence / Profile preview

Ribosomal protein L11 pseudogene 2 (RPL11P2)

Target
RPL11P2
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L11 pseudogene 2 (RPL11P2) is a processed pseudogene in the human genome related to the functional ribosomal protein L11 gene (RPL11), which encodes a component of the 60S ribosomal subunit involved in cellular protein synthesis. RPL11P2 does not produce a functional protein, has no established biological role, and is not associated with disease pathogenesis or therapeutic targeting. Pseudogenes such as RPL11P2 are primarily considered relics of evolution without current biological function, although their transcripts may occasionally have regulatory functions in rare cases, which is not documented here. If you are seeking druggable targets related to ribosomal function, the appropriate entry would be the protein-coding gene RPL11 (Ribosomal protein L11), not its pseudogene.

Other names
RPL11_1_612RPL11P2Ribosomal protein L11 pseudogene 2
02

Mechanism of action

Not applicable; pseudogene does not have protein product or known biological activity relevant to drug action

03

Biological functions

No established biological function for the pseudogene itselfParent gene (RPL11) is involved in ribosome structure and protein synthesis
04

Disease associations

None directly for the pseudogene.Parent gene RPL11 associated with Diamond-Blackfan anemia and certain cancers; no evidence or associations documented for RPL11P2
05

Safety considerations

Not applicable; as a non-coding pseudogene, there are no known safety concerns or therapeutic challenges
06

Interacting drugs

None known or documented for the pseudogene
07

Biomarkers

None reported for this pseudogene; some pseudogene-derived RNAs from other loci may serve as biomarkers, but there is no such evidence for RPL11P2 specifically

Beyond the preview

Go deeper on Ribosomal protein L11 pseudogene 2 (RPL11P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L11 pseudogene 2 (RPL11P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call